Compugen Ltd. (CGEN)
2.58
+0.10
(+4.03%)
USD |
NASDAQ |
Apr 10, 16:00
2.60
+0.02
(+0.78%)
After-Hours: 20:00
Compugen EPS Diluted (Quarterly) : 0.6002 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 0.4118 |
| Pluri, Inc. | -0.7066 |
| BioLineRx Ltd. | -0.32 |
| XTL Biopharmaceuticals Ltd. | -0.1169 |
| Can-Fite BioPharma Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 56.84M |
| Revenue (Quarterly) | 67.33M |
| Total Expenses (Quarterly) | 10.49M |
| Enterprise Value | 101.27M |
| Gross Profit Margin (Quarterly) | 94.75% |
| Profit Margin (Quarterly) | 84.42% |
| Earnings Yield | 14.31% |
| Operating Earnings Yield | 12.98% |
| Normalized Earnings Yield | 14.31 |